Sector
PharmaceuticalsOpen
₹993.55Prev. Close
₹988.6Turnover(Lac.)
₹7,091.31Day's High
₹1,002.85Day's Low
₹982.252 Week's High
₹1,22052 Week's Low
₹795Book Value
₹214.41Face Value
₹1Mkt Cap (₹ Cr.)
99,496.42P/E
22.32EPS
44.31Divi. Yield
1.111 Aug 2025
12:00 AM
Board Meeting
Agenda : Audited Result
19 May 2025
12:00 AM
Dividend
Dividend Amount: 11
Record Date: 25 Jul, 2025
20 May 2025
12:00 AM
AGM
Announcement Date: 20 May, 2025
The company said it will work with the US regulator to resolve the points raised as quickly as possible.
This development comes after a USFDA inspection at one of Zydus' oncology facilities earlier this year.
In its filing with the bourses, Zydus informed that these observations received were minor, and not related to data integrity.
Here are some of the stocks that may see significant price movement today: Jio Financial Service, Hero MotoCorp, Abbott India, etc.
Here are some of the stocks that may see significant price movement today: Hindustan Copper, Maruti Suzuki, Zydus Lifesciences, etc.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 100.6 | 100.6 | 101.2 | 102.4 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 21,089.5 | 15,615.9 | 13,538.2 | 13,138.1 |
Net Worth | 21,190.1 | 15,716.5 | 13,639.4 | 13,240.5 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 7,981.9 | 7,780 | 6,347.4 | 5,809.9 |
yoy growth (%) | 2.59 | 22.56 | 9.25 | 79.83 |
Raw materials | -2,870.2 | -2,351.4 | -1,951.7 | -1,695.7 |
As % of sales | 35.95 | 30.22 | 30.74 | 29.18 |
Employee costs | -1,204.9 | -1,147.3 | -1,077.4 | -826 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1,483.2 | 1,876 | 1,609.7 | 1,497.2 |
Depreciation | -478.7 | -451.1 | -428.9 | -293.1 |
Tax paid | -306 | -212.3 | -204.1 | -406.4 |
Working capital | 607.49 | 991.9 | 1,239 | 1,462.2 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 2.59 | 22.56 | 9.25 | 79.83 |
Op profit growth | -16.91 | 62.23 | -13.55 | 412.7 |
EBIT growth | -16.88 | 5.6 | 18.09 | 138.95 |
Net profit growth | -41.88 | 4.48 | 29.52 | 64.79 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 22,573.8 | 19,021.5 | 16,877.8 | 14,827.6 | 14,125 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 22,573.8 | 19,021.5 | 16,877.8 | 14,827.6 | 14,125 |
Other Operating Income | 667.7 | 525.9 | 359.6 | 282.3 | 278.5 |
Other Income | 269.5 | 307.1 | 186.6 | 2,583.1 | 45.6 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,641.4 | 79.12 | 3,94,114.76 | 753.53 | 0.97 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,132.5 | 69.66 | 1,62,734.89 | 557 | 0.49 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,564 | 24.45 | 1,26,312.54 | 1,303.13 | 1.02 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,623 | 61.66 | 1,22,586.2 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,260.4 | 15.25 | 1,05,094.71 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Pankaj R Patel
Managing Director
Sharvil P Patel
Non Executive Director
Mukesh M Patel
Independent Director
Apurva S Diwanji
Whole-time Director
Ganesh N Nayak
Independent Director
Bhadresh K Shah
Company Sec. & Compli. Officer
Dhaval N Soni
Independent Director
Akhil A. Monappa
Independent Director
Upasana Konidela.
Independent Director
Shelina P. Parikh
Zydus Corporate Park S No 536,
Khoraj Sarkhej-Gandhinagar H/W,
Gujarat - 382481
Tel: 91-079-26868100
Website: http://www.zyduscadila.com
Email: dhavalsoni@zyduscadila.com; upen.shah@zyduscadila.
5th Floor 506 to 508,
ABC-I Off C G Road, Navrangpura,
Ahmedabad-380009
Tel: 91-79-26465179
Website: https://in.mpms.mufg.com/
Email: ipo.team@linkintime.co.in
Summary
Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022. The Company is one of the lead...
Read More
Reports by Zydus Lifesciences Ltd
What is the Zydus Lifesciences Ltd share price today?
What is the Market Cap of Zydus Lifesciences Ltd?
What is the PE and PB ratio of Zydus Lifesciences Ltd?
What is the 52 Week High and Low of Zydus Lifesciences Ltd?
What is the CAGR of Zydus Lifesciences Ltd?
What is the shareholding pattern of Zydus Lifesciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
